MetLife Investment Management’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

MetLife Investment Management’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,912	Closed	-$408K	–	2258
2018 Q1	$408K	Buy	+10,912	New	+$459K	﹤0.01%	1491

MetLife Investment Management's ARMO Position: Q2 2018 in Review

MetLife Investment Management sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 10,912 shares — an estimated $408K sold.

MetLife Investment Management first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $408K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

MetLife Investment Management reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
MetLife Investment Management sold 10,912 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $408K.
MetLife Investment Management first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
MetLife Investment Management's ARMO BioSciences, Inc. Common Stock position peaked at $408K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.